TITLE 68: PROFESSIONS AND OCCUPATIONS
CHAPTER VII: DEPARTMENT OF FINANCIAL AND PROFESSIONAL REGULATION
SUBCHAPTER b: PROFESSIONS AND OCCUPATIONS
PART 1330 PHARMACY PRACTICE ACT
SECTION 1330.310 GRADUATES OF PROGRAMS OUTSIDE THE UNITED STATES


 

Section 1330.310  Graduates of Programs Outside the United States

 

Applicants who are graduates of a first professional degree program in pharmacy located outside the United States or its territories that is not approved pursuant to the provisions of Section 1330.300 shall submit proof of:

 

a)         Submission of a Foreign Pharmacy Graduate Examination Committee (FPGEC) Certificate;

 

b)         Passage of the preliminary diagnostic examination (Foreign Pharmacy Graduate Equivalency Exam (FPGEE)) designed to determine equivalence of education to programs approved pursuant to Section 1330.300;

 

c)         The minimum acceptable scores are 550 for the paper TOEFL and 50 for the paper TSE, or 213 for the computer-based TOEFL and TSE combination, or 88 for the Internet-based TOEFL iBT with a minimum score of 26 on the speaking module;

 

d)         Passage of the Test of Spoken English (TSE) examination with a score of 50; and

 

e)         Either:

 

1)         Completion of a course of clinical instruction totaling 1,200 clinical hours approved by the Board as required by Section 7 of the Act.  The course of clinical instruction shall be conducted under the supervision of a pharmacist registered in the State of Illinois.  The applicant shall obtain prior approval of the Board before enrolling in the course of clinical instruction.  In approving a course of clinical instruction, the Board shall consider, but not be limited to, whether the course:

 

A)        Enhances development of effective communication skills by enabling consultation among the applicant, the prescriber and the patient;

 

B)        Promotes development of medical data retrieval skills through exposure to patient medical charts, patient medication profiles and other similar sources of patient information;

 

C)        Promotes development of the applicant's ability to research and analyze drug information literature; and

 

D)        Promotes development of the applicant's ability to interpret laboratory test and physical examination results; or

 

2)         Have been licensed in a U.S. jurisdiction or territory for at least 1 year with no disciplinary actions or encumbrances on their license or pending license.